Summit Therapeutics shares owned by Affinity Asset Advisors
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Affinity Asset Advisors
from 13F filings
Historical chart of Affinity Asset Advisors investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Affinity Asset Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.2M | 350k | 20.66 |
| 2024-09-30 | $3.1M | 140k | 21.90 |